Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer.

Kuba, Sayaka

Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer. [electronic resource] - Breast cancer (Tokyo, Japan) Jan 2016 - 128-133 p. digital

Publication Type: Journal Article

1880-4233

10.1007/s12282-014-0540-4 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Hormonal--therapeutic use
Aromatase Inhibitors--therapeutic use
Breast Neoplasms--drug therapy
Carcinoma--drug therapy
Chemotherapy, Adjuvant--statistics & numerical data
Cohort Studies
Drug Costs
Drug-Related Side Effects and Adverse Reactions
Female
Gonadotropin-Releasing Hormone--agonists
Humans
Japan
Lymph Nodes--pathology
Mastectomy
Middle Aged
Neoplasm Staging
Receptor, ErbB-2--metabolism
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Retrospective Studies
Selective Estrogen Receptor Modulators--therapeutic use
Young Adult
Assessment of Medication Adherence